Privi Speciality Chemicals Q1 FY26 results: PAT up 23% YoY standalone, 44% consolidated

Pat Growth 25pctResults View source PDF Explain this filing

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.4%Reaction day

₹3695.00

prior close

₹3720.80

announcement price

In-mkt

timing

Nifty Microcap 250market-0.6%-1.9% vs market

Specialty Chemicals peers, median of 93sector-1.3%-1.1% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.4-0.6-1.9-1.3-1.1

Next day

-1.8+0.5-2.3-0.7-1.0

-2.8+1.9-4.7+0.2-3.1

-0.9+2.3-3.2+0.0-0.9

-1.4+3.6-5.0+0.3-1.7

-1.4+4.0-5.4+1.5-2.9

-2.5+4.0-6.5+0.9-3.4

15d

-6.5+4.9-11.4+1.2-7.7

-6.1+5.9-12.0+3.5-9.6

-3.5+4.8-8.3+1.7-5.2

-11.4pendingpending-7.5-3.8

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 93Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Privi Speciality Chemicals posted Q1 FY26 standalone revenue of Rs 600.59 crore, up 6% YoY from Rs 566.36 crore, with net profit rising 23% to Rs 84.26 crore. Consolidated revenue grew 19% to Rs 666.22 crore and PAT jumped 44% to Rs 82.84 crore. EPS stood at Rs 21.57 (standalone) and Rs 21.56 (consolidated). Auditors gave an unmodified review. Board had recommended Rs 10 per share final dividend and filed an amalgamation scheme with NCLT to merge two subsidiaries.

Likely market impact

Strong consolidated earnings growth signals business momentum. Unmodified audit opinion and ongoing subsidiary consolidation are supportive for shareholders.